HIV Clinical Studies Beth Israel Listing St. Luke's-Roosevelt Listing Beth Israel For complete information about Beth Israel's AIDS Clinical Trials Unit, click here or call (800) 483-7339. Anti-HIV Therapy Experienced and Virologically Suppressed INCB 8721 RVT-203; A Placebo-Controlled, Double-Blind, Parallel Dose Group Study Exploring the Safety, Tolerability, and Virological Effect of 50, 100, and 200 mg Reversettm (RVT, an NRTI) in HIV-Infected Antiretroviral Therapy-Experienced Subjects when used in Combination with Other Antiretroviral Agents Studies for Women Anti-HIV Therapy Experienced and Virologically Failing ACTG A5216; A Randomized Phase II Study of the Safety, Immunologic and Virologic Effects of Cyclosporine A in Conjunction with Trizivir and Kaletra versus Trizivir and Kaletra Alone during Primary HIV-1 Infection ACTG A5146: Evaluating the Impact of Therapeutic Drug Monitoring (TDM) on Virologic Response to a Salvage Regimen. Complications of HIV Treatment Studies ACTG A5157; Using the Amino Acid Acetyl-L-Carnitine for the Treatment of Dideoxynucleoside (d-drug) Associated Peripheral Neuropathy ACTG A5178; Suppressive Long-Term Antiviral Management of Hepatitis C Virus (HCV) and HIV-1 Co-Infected Subjects (SLAM-C) For more information on the above studies, please email us at sbarnett@chpnet.org or call (212) 420-4519. St. Luke's-Roosevelt There are no studies at this time. Please check back at a later date.   For more information on these studies, send inquiries to: info@WeHealNewYork.org